<DOC>
	<DOC>NCT01481402</DOC>
	<brief_summary>Purpose: The purpose of the study is to examine if treatment with liothyronine increases left ventricular ejection fraction (LVEF) in patients with stable, chronic heart failure.</brief_summary>
	<brief_title>Liothyronine and Heart Failure. The Long Term Effect of Liothyronine on Left Ventricular Ejection Fraction (LVEF)</brief_title>
	<detailed_description>The patients are examined 3 times. At baseline, after 3 months and after 6 months.After the examination is performed, they begin the study medication while admitted at Dept. of Cardiology, Herlev Hospital, for cardiac monitoring.</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Euthyroid Sick Syndromes</mesh_term>
	<criteria>Patients with stable, chronic systolic heart failure T3 ≤1.4 nmol/l in two blood samples, TSH is to be normal LVEF ≤ 45 % on prior echocardiography Established thyroid illness Atrial fibrillation/flutter More than 20% ventricular extrasystoles Severe chronic obstructive lung disorder Pregnancy. Pregnancy testing will be done for fertile women Age &lt; 18 years</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>Heart failure</keyword>
	<keyword>Liothyronine</keyword>
	<keyword>Low T3 syndrome</keyword>
</DOC>